Published in Obesity and Diabetes Week, December 27th, 2004
Surveyed primary care physicians are more sensitive to cost and formulary status of anti-diabetic agents than are endocrinologists.
"More primary care physicians than endocrinologists cite these two reasons as significant factors that influence their choice of therapies," said Donny Wong, PhD, analyst at Decision Resources. "Endocrinologists, on the other hand, are uniformly more concerned about safety and side effects than are primary care physicians."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.